October 27, 2014 by Brad Perriello
Smith & Nephew says the U.S. Patent & Trademark Office confirmed the validity of a patent at issue in an ongoing infringement battle with Arthrex.
Smith & Nephew (FTSE:SN, NYSE:SNN) today claimed another win in an ongoing patent infringement war with Arthrex, saying the U.S. Patent & Trademark Office affirmed the validity of 1 of its patents.
Last year a federal judge barred Arthrex from selling some of its suture anchors in the U.S. until the expiration of U.S Patent 5601557, for “Anchoring and manipulating tissue.”
Arthrex asked the patent office to re-examine the patent after that ruling, by Judge Michael Mosman of the U.S. District Court for Oregon. Today Smith & Nephew said the USPTO “issued a decision confirming the validity” of the ‘557 patent.
